IRIS
PLATANIA, CHIARA BIANCA MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.517
EU - Europa 1.089
AS - Asia 1.080
AF - Africa 281
SA - Sud America 233
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 5.207
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.450
IT - Italia 525
SG - Singapore 459
CN - Cina 421
BR - Brasile 204
IE - Irlanda 201
CI - Costa d'Avorio 182
UA - Ucraina 87
DE - Germania 74
SN - Senegal 70
KR - Corea 64
CA - Canada 45
RU - Federazione Russa 41
GB - Regno Unito 37
VN - Vietnam 31
IN - India 28
FI - Finlandia 25
SE - Svezia 25
JP - Giappone 20
MX - Messico 15
AR - Argentina 14
PL - Polonia 13
NL - Olanda 11
FR - Francia 10
HK - Hong Kong 10
BD - Bangladesh 9
BE - Belgio 8
NG - Nigeria 8
ES - Italia 7
ZA - Sudafrica 7
CH - Svizzera 6
TR - Turchia 6
AT - Austria 5
EC - Ecuador 5
KE - Kenya 5
AE - Emirati Arabi Uniti 4
CZ - Repubblica Ceca 4
EU - Europa 4
IQ - Iraq 4
MA - Marocco 4
TN - Tunisia 4
AU - Australia 3
CO - Colombia 3
GR - Grecia 3
ID - Indonesia 3
NP - Nepal 3
PY - Paraguay 3
UZ - Uzbekistan 3
AL - Albania 2
AZ - Azerbaigian 2
JO - Giordania 2
KG - Kirghizistan 2
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
CL - Cile 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GH - Ghana 1
GT - Guatemala 1
IL - Israele 1
IM - Isola di Man 1
JM - Giamaica 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
NI - Nicaragua 1
OM - Oman 1
PE - Perù 1
PK - Pakistan 1
SA - Arabia Saudita 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
YE - Yemen 1
Totale 5.207
Salva come PNG Salva come JPEG
Città #
Santa Clara 436
Dallas 420
Chandler 321
Singapore 287
Dublin 201
Abidjan 182
Catania 167
Chicago 159
Hefei 120
Jacksonville 94
Houston 86
Boardman 82
Dakar 70
Ashburn 69
Beijing 68
Seoul 61
Cambridge 48
Lawrence 47
Andover 43
Civitanova Marche 35
Los Angeles 28
Toronto 27
Wilmington 27
Des Moines 24
Nanjing 23
Bremen 21
Rome 21
São Paulo 19
The Dalles 18
Seattle 17
Aci Catena 16
Columbus 16
Falls Church 16
Messina 16
Tokyo 16
Council Bluffs 15
New York 15
Milan 13
Palermo 13
Lappeenranta 12
Munich 12
Rio de Janeiro 12
Redwood City 11
Boydton 10
Changsha 10
Dong Ket 10
Hebei 10
Ottawa 10
Saint Petersburg 10
Shenyang 10
Warsaw 10
Belo Horizonte 9
Mumbai 9
Naples 9
San Mateo 9
Abuja 8
Brooklyn 8
Grafing 8
Ho Chi Minh City 8
Redmond 8
Hong Kong 7
Jiaxing 7
Manchester 7
Nanchang 7
San Gregorio di Catania 7
Dearborn 6
Guangzhou 6
Hanoi 6
Pozzallo 6
Rosolini 6
Shanghai 6
Stockholm 6
Brasília 5
Bronte 5
Brussels 5
Cagliari 5
Curitiba 5
Hyderabad 5
Manaus 5
Mexico City 5
Nairobi 5
Phoenix 5
San Francisco 5
Turku 5
Washington 5
Baranzate 4
Boston 4
Busto Garolfo 4
Città Sant'Angelo 4
Denver 4
Helsinki 4
Jinan 4
Johannesburg 4
London 4
Moscow 4
Ningbo 4
Novara 4
Pune 4
Tianjin 4
Turin 4
Totale 3.762
Salva come PNG Salva come JPEG
Nome #
Current drug treatments targeting dopamine D3 receptor 189
Antioxidant and osmoprotecting activity of taurine in dry eye models 142
Computational systems biology approach to identify novel pharmacological targets for diabetic retinopathy 118
Innovative Nanoparticles Enhance N-Palmitoylethanolamide Intraocular Delivery 116
Caffeine Protects Against Retinal Inflammation 115
Retinal biomarkers and pharmacological targets for Hermansky-Pudlak syndrome 7 115
Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment 114
Effects of Novel Nitric Oxide-Releasing Molecules against Oxidative Stress on Retinal Pigmented Epithelial Cells 112
Blood-retinal barrier protection against high glucose damage: The role of P2X7 receptor 109
Glucose-impaired Corneal Re-epithelialization Is Promoted by a Novel Derivate of Dimethyl Fumarate 108
Influence of different surfactants on the technological properties and in vivo ocular tolerability of lipid nanoparticles. 106
Aflibercept regulates retinal inflammation elicited by high glucose via the PlGF/ERK pathway 106
Anti-angiogenic and antioxidant effects of axitinib in human retinal endothelial cells: implications in diabetic retinopathy 101
P2X7 receptor antagonism: implications in diabetic retinopathy 98
Controversies in Glaucoma: Current Medical Treatment and Drug Development 96
Tgf-β serum levels in diabetic retinopathy patients and the role of anti-vegf therapy 96
Effects of topical indomethacin, bromfenac and nepafenac on lipopolysaccharide-induced ocular inflammation 90
Drug delivery of synthetic antisense “Bioconjugates” for anticancer therapy DNA. 90
1α,25-dihydroxyvitamin D3 protects retinal ganglion cells in glaucomatous mice 90
Retinal and Circulating miRNAs in Age-Related Macular Degeneration: An In vivo Animal and Human Study 89
Dopamine D-3 receptor as a new pharmacological target for the treatment of depression 89
Topical ocular delivery of TGF-β1 to the back of the eye: Implications in age-related neurodegenerative diseases 88
Homology modeling of dopamine D2 and D3 receptors: molecular dynamics refinement and docking evaluation 87
Novel ophthalmic formulation of myriocin: implications in retinitis pigmentosa 86
Molecular features of interaction between VEGFA and anti-angiogenic drugs used in retinal diseases: a computational approach 86
Fingolimod and Diabetic Retinopathy: A Drug Repurposing Study 85
Vitamin D3 preserves blood retinal barrier integrity in an in vitro model of diabetic retinopathy 85
Retinal protection and distribution of curcumin in vitro and in vivo 85
Dihydrotanshinone, a natural diterpenoid, preserves blood-retinal barrier integrity via p2x7 receptor 85
Novel therapeutics in glaucoma management 80
New Brilliant Blue G Derivative as Pharmacological Tool in Retinal Surgery 79
Blockade of P2X7 receptors preserves blood retinal barrier integrity by modulating the plasmalemma vesicle-associated protein: Implications for diabetic retinopathy 79
Fortified extract of red berry, Ginkgo biloba, and white willow bark in experimental early diabetic retinopathy 79
DRUG DELIVERY OF SYNTHETIC ANTISENSE-DNA "BIOCONJUGATES" FOR ANTICANCER THERAPY 79
Dopamine D3 receptor-dependent changes in alpha6 GABAA subunit expression in striatum modulate anxiety-like behaviour: Responsiveness and tolerance to diazepam 79
TGF-β1 prevents rat retinal insult induced by amyloid-β (1–42) oligomers 79
Drug Delivery of Synthetic Antisense-DNA “bioconjugates” for Anticancer Therapy 78
Synthesis, in vitro and in silico studies of HO-1 inducers and lung antifibrotic agents 78
Novel indole derivatives targeting HuR-mRNA complex to counteract high glucose damage in retinal endothelial cells 77
Assessment of a new nanostructured microemulsion system for ocular delivery of sorafenib to posterior segment of the eye 74
Retinal pharmacodynamic and pharmacokinetic profile of cannabidiol in an in vivo model of retinal excitotoxicity 73
Ocular pharmacological profile of hydrocortisone in dry eye disease 73
Do extracellular RNAs provide insight into uveal melanoma biology? 72
Dopamine D3 receptor is necessary for ethanol consumption: an approach with buspirone 71
Ocular allergy 66
Novel heme oxygenase-1 (Ho-1) inducers based on dimethyl fumarate structure 66
Effects of protein-protein interface disruptors at the ligand of the glucocorticoid-induced tumor necrosis factor receptor-related gene (GITR) 66
Effects of Vitamin D3 and Meso-Zeaxanthin on Human Retinal Pigmented Epithelial Cells in Three Integrated in vitro Paradigms of Age-Related Macular Degeneration 66
In-Silico Characterization of von Willebrand Factor Bound to FVIII 64
MicroRNA target prediction in glaucoma 64
Editorial: Chronic Inflammation and Neurodegeneration in Retinal Disease 63
Circulating miRNAs in diabetic retinopathy patients: Prognostic markers or pharmacological targets? 63
Molecular basis of alcohol intake: role of D3 dopaminergic receptor 63
Resolvin D1 Modulates the Intracellular VEGF-Related miRNAs of Retinal Photoreceptors Challenged With High Glucose 62
Integrating network pharmacology: The next-generation approach in ocular drug discovery 61
Characterization of protein-protein interfaces through a protein contact network approach 59
Stabilization of HIF-1α in Human Retinal Endothelial Cells Modulates Expression of miRNAs and Proangiogenic Growth Factors 58
Implications of dopamine D3 receptor for glaucoma: in-silico and in-vivo studies 53
The P2X7 receptor as a new pharmacological target for retinal diseases 53
Ocular pharmacological and biochemical profiles of 6-thioguanine: a drug repurposing study 50
Retinal and circulating miRNA expression patterns in diabetic retinopathy: An in silico and in vivo approach. 46
Molecular Dynamics Simulation Techniques as Tools in Drug Discovery and Pharmacology: A Focus on Allosteric Drugs 44
Erratum: Homology modeling of dopamine D2 and D3 receptors: Molecular dynamics refinement and docking evaluation (PLoS ONE (2013) 8:1 DOI: 10.1371/annotation/bd61cc74-2a2c-4433-a78d-84fa2310e919) 43
Ocular Allergies 40
α1D Adrenergic Receptor Antagonism Protects Against High Glucose-Induced Mitochondrial Dysfunction and Blood Retinal Barrier Breakdown in ARPE-19 Cells 30
The Identification of New Pharmacological Targets for the Treatment of Glaucoma: A Network Pharmacology Approach 29
Targeting the miRNA-155/TNFSF10 network restrains inflammatory response in the retina in a mouse model of Alzheimer’s disease 3
Totale 5.338
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.213
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.213
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021189 0 0 0 3 53 13 34 5 19 15 27 20
2021/2022385 31 45 10 6 50 18 64 21 32 6 19 83
2022/2023927 61 66 17 109 121 120 16 170 173 16 31 27
2023/2024403 32 43 18 21 31 115 7 30 1 3 57 45
2024/20251.769 42 254 75 128 373 242 100 56 129 106 152 112
2025/20261.160 243 184 604 129 0 0 0 0 0 0 0 0
Totale 5.338